P63784 (CLPP2_MYCBO) Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)
ATP-dependent Clp protease proteolytic subunit 2 UniProtKBInterProInteractive Modelling
214 aa; Sequence (Fasta) ;
14 identical sequences
Available Structures
15 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| crystal structure of the active form of the proteolytic complex clpP1 and clpP2 |
Heteromer P9WPC3; P9WPC5; | 100 | ||||
| Crystal structure of the active form of the proteolytic complex clpP1 and clpP2 |
Heteromer P9WPC3; P9WPC5; | 100 | ||||
| Crystal Structure of M. tuberculosis ClpP1P2 bound to ADEP and agonist |
Heteromer P9WPC3; P9WPC5; | 100 | 14×ZIL; 17×SO4; 8×DMS; 7×39Y; | |||
| structural insights into Mycobacterium tuberculosis ClpP1P2 inhibition by Cediranib: implications f… |
Heteromer P9WPC3; P9WPC5; | 100 | 7×AI4; | |||
| ClpP1P2 complex from M. tuberculosis bound to ADEP |
Heteromer P9WPC3; P9WPC5; | 100 | ||||
| CryoEM structure of M. tuberculosis ClpXP1P2 complex bound to bortezomib |
Heteromer P9WPB9; P9WPC3; P9WPC5; | 100 | 2×MG; 4×ATP; 2×ADP; 14×BO2; | |||
| structural insights into Mycobacterium tuberculosis ClpP1P2 inhibition by Cediranib: implications f… |
Heteromer P9WPC3; P9WPC5; | 100 | 2×S0R; 2×LEU; 2×AV3; | |||
| ClpP1P2 complex from M. tuberculosis |
Heteromer P9WPC3; P9WPC5; | 100 | ||||
| CryoEM structure of M. tuberculosis ClpC1P1P2 complex bound to bortezomib, conformation 2 |
Heteromer P9WPC3; P9WPC5; P9WPC9; Q9TSI0; | 100 | 4×ADP; 7×ATP; 7×MG; 14×BO2; | |||
| CryoEM structure of apo M. tuberculosis ClpP1P2 |
Heteromer P9WPC3; P9WPC5; | 100.0 | ||||
| CryoEM structure of M. tuberculosis ClpC1P1P2 complex bound to bortezomib, conformation 1 |
Heteromer P02666; P9WPC3; P9WPC5; P9WPC9; | 100 | 7×MG; 7×ATP; 3×ADP; 14×BO2; | |||
| CryoEM structure of M. tuberculosis ClpC1P1P2 complex bound to bortezomib, conformation 3 |
Heteromer P02666; P9WPC3; P9WPC5; P9WPC9; | 100 | 8×ATP; 8×MG; 4×ADP; 14×BO2; | |||
| ClpP1P2 complex from M. tuberculosis with GLF-CMK bound to ClpP1 |
Heteromer P9WPC3; P9WPC5; | 100 | ||||
| CryoEM structure of M. tuberculosis ClpP1P2 bound to bortezomib |
Heteromer P9WPC3; P9WPC5; | 100 | 14×BO2; | |||
| CryoEM structure of M. tuberculosis ClpP1P2 bound to bortezomib |
Heteromer P9WPC3; P9WPC5; | 100 | 14×BO2; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5e0s.2.E | monomer | 0.86 | 100.00 | |||
| 6naq.1.A | homo-14-mer | 0.81 | 50.00 | |||